This article has been corrected: The correct author information is given below:
Satdarshan P. Monga
Original article: Oncotarget. 2019; 10:1475–1490. 1475-1490. https://doi.org/10.18632/oncotarget.26668
. 2019 Sep 24;10(54):5670. doi: 10.18632/oncotarget.27218
Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development
Laura Molina
1,2,#, Hong Yang
3,#, Adeola O Adebayo Michael
4, Michael Oertel
1,5, Aaron Bell
1, Sucha Singh
1, Xin Chen
6, Junyan Tao
1,✉, Satdarshan P Monga
1,5,7,✉
Laura Molina
1 Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
2 Medical Scientist Training Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Find articles by Laura Molina
Hong Yang
3 Department of Medical Ultrasonics, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China
Find articles by Hong Yang
Adeola O Adebayo Michael
4 Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
Find articles by Adeola O Adebayo Michael
Michael Oertel
1 Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
5 Pittsburgh Liver Research Center, University of Pittsburgh Medical Center and University of Pittsburgh School of Medicine, Pittsburgh PA, USA
Find articles by Michael Oertel
Aaron Bell
1 Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Find articles by Aaron Bell
Sucha Singh
1 Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Find articles by Sucha Singh
Xin Chen
6 Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, CA, USA
Find articles by Xin Chen
Junyan Tao
1 Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Find articles by Junyan Tao
Satdarshan P Monga
1 Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
5 Pittsburgh Liver Research Center, University of Pittsburgh Medical Center and University of Pittsburgh School of Medicine, Pittsburgh PA, USA
7 Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Find articles by Satdarshan P Monga
1 Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
2 Medical Scientist Training Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
3 Department of Medical Ultrasonics, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China
4 Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
5 Pittsburgh Liver Research Center, University of Pittsburgh Medical Center and University of Pittsburgh School of Medicine, Pittsburgh PA, USA
6 Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, CA, USA
7 Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
✉
Correspondence to: Satdarshan P.S. Monga, smonga@pitt.edu
✉
Junyan Tao, junyantao2010@gmail.com
#
Contributed equally.
Collection date 2019 Sep 24.
Copyright: © 2019 Molina et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PMCID: PMC6771459 PMID: 31645895
This corrects the article "mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development" on page 1475.